BRIEF published on 12/16/2025 at 21:23, 3 months 7 days ago ABIONYX Pharma Annonce une Augmentation de Capital Augmentation De Capital Biopharmaceutique Levée De Fonds ABIONYX Pharma Sepsis
BRIEF published on 12/16/2025 at 21:23, 3 months 7 days ago ABIONYX Pharma annonce une augmentation de capital de 1,8 million d'euros. Augmentation De Capital Cotation Euronext Visibilité Financière ABIONYX Pharma Droits D'abonnement
BRIEF published on 12/16/2025 at 21:23, 3 months 7 days ago ABIONYX Pharma Announces a Capital Increase Fundraising Capital Increase Biopharmaceutical ABIONYX Pharma Sepsis
PRESS RELEASE published on 12/16/2025 at 21:18, 3 months 7 days ago Inside Information / Other news releases ABIONYX Pharma launches €1.8m capital increase with removal of preferential subscription rights, subscription price at 3.10 euros for new shares, extending financial visibility until 2026 Capital Increase Biopharma Preferential Subscription Rights ABIONYX Pharma Financial Visibility
PRESS RELEASE published on 12/16/2025 at 21:18, 3 months 7 days ago Informations privilégiées / Autres communiqués ABIONYX Pharma lance une augmentation de capital de 1,8M€ avec suppression du droit préférentiel de souscription à 3,10 euros par action et extension de la visibilité jusqu'à fin 2026 Augmentation De Capital Droit Préférentiel De Souscription ABIONYX Pharma Visibilité 3,10 Euros
BRIEF published on 12/05/2025 at 18:05, 3 months 18 days ago ABIONYX publie des données mensuelles sur les droits de vote et les actions Euronext Paris Capital Social Droit De Vote ABIONYX Pharma Règlementation De L'AMF
BRIEF published on 12/05/2025 at 18:05, 3 months 18 days ago ABIONYX Reports Monthly Voting Rights and Share Data Euronext Paris Share Capital Voting Rights AMF Regulations ABIONYX Pharma
PRESS RELEASE published on 12/05/2025 at 18:00, 3 months 18 days ago Inside Information / Other news releases ABIONYX Pharma discloses monthly statement of total voting rights and shares as per French regulations. Company focused on innovative medicines in rare diseases Shares French Regulations Total Voting Rights ABIONYX Pharma Innovative Medicines
BRIEF published on 11/25/2025 at 18:38, 3 months 28 days ago ABIONYX Pharma Releases Q3 2025 Business Update Revenue Financial Update ABIONYX Pharma Q3 2025 Sepsis Research
BRIEF published on 11/25/2025 at 18:38, 3 months 28 days ago ABIONYX Pharma publie ses prévisions d'activité pour le troisième trimestre 2025 Mise À Jour Financière Revenu ABIONYX Pharma 3e Trimestre 2025 Recherche Sur La Septicémie
Published on 03/24/2026 at 10:10, 1 hour 17 minutes ago BioNxt Enters Commercialization Phase with Global Patent Protection and U.S. Fast Track Strategy for Sublingual Drug Delivery Platform
Published on 03/24/2026 at 08:01, 3 hours 26 minutes ago Star Copper Confirms Copper Creek Mineralization
Published on 03/24/2026 at 07:00, 4 hours 27 minutes ago Panther Minerals Earns In Under Rubidium Ridge Project Option
Published on 03/24/2026 at 07:00, 4 hours 27 minutes ago Panther Completes Acquisition of Rubidium Ridge Project
Published on 03/24/2026 at 11:16, 11 minutes ago Original-Research: Vossloh AG (von Quirin Privatbank Kapitalmarktgeschäft): BUY
Published on 03/24/2026 at 11:05, 22 minutes ago Furniture China Announces Landmark 2026 Edition: Where Design Creates Business
Published on 03/24/2026 at 11:00, 27 minutes ago GBC AG re-initiates coverage on Aspermont Ltd. – subscription-led platform model and Mining IQ offer attractive margin upside
Published on 03/24/2026 at 10:45, 42 minutes ago iGarden Lauches the L AWD Series: The World's First 8-Hour-Endurance 4WD Robotic Mower
Published on 03/24/2026 at 10:36, 51 minutes ago Original-Research: init innovation in traffic systems SE (von Quirin Privatbank Kapitalmarktgeschäft): Buy
Published on 03/24/2026 at 10:58, 29 minutes ago Statement about the number of shares composing the share capital and the number of voting rights as of February 28, 2026
Published on 03/24/2026 at 10:58, 29 minutes ago Déclaration du nombre d'actions composant le capital social et du nombre total de droits de vote au 28 février 2026
Published on 03/24/2026 at 07:45, 3 hours 42 minutes ago François Jackow’s appointment as a Board member will be submitted to the Annual General Meeting on May 7, 2026
Published on 03/24/2026 at 07:45, 3 hours 42 minutes ago La nomination de François Jackow en tant que membre du Conseil d’administration sera soumise à l’Assemblée générale du 7 mai 2026
Published on 03/24/2026 at 07:30, 3 hours 57 minutes ago Gimv secures new EUR 400 million revolving credit facility to support accelerated growth ambitions
